Cargando…

Sexual Dysfunction in Menopausal Women

INTRODUCTION: Hormone-related changes in menopause may negatively affect sexual function. AIM: The primary aim of this study was to evaluate sexual functioning in Polish women with the Female Sexual Function Index (FSFI). The secondary aim was to evaluate the major factors affecting sexual functions...

Descripción completa

Detalles Bibliográficos
Autores principales: Dąbrowska-Galas, Magdalena, Dąbrowska, Jolanta, Michalski, Bogdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963159/
https://www.ncbi.nlm.nih.gov/pubmed/31371259
http://dx.doi.org/10.1016/j.esxm.2019.06.010
_version_ 1783488222133747712
author Dąbrowska-Galas, Magdalena
Dąbrowska, Jolanta
Michalski, Bogdan
author_facet Dąbrowska-Galas, Magdalena
Dąbrowska, Jolanta
Michalski, Bogdan
author_sort Dąbrowska-Galas, Magdalena
collection PubMed
description INTRODUCTION: Hormone-related changes in menopause may negatively affect sexual function. AIM: The primary aim of this study was to evaluate sexual functioning in Polish women with the Female Sexual Function Index (FSFI). The secondary aim was to evaluate the major factors affecting sexual functions in middle-aged Polish women. METHODS: The Menopause Rating Scale was used to assess the menopausal symptoms. The Polish translation of the FSFI was used to assess sexual function. OUTCOMES: 69.73% of respondents had sexual dysfunction according to FSFI (FSFI score ≤ 26.55). RESULTS: 80.61% of women experienced menopausal symptoms during the 4-week period of study. Psychological and urogenital symptoms were the most frequently reported among all the women enrolled in the study (78.23% and 77.21%). Sexual problems were observed in women who did not use hormone therapy (β = 0.09, t = −1.97, P = .048) and showed no somatic symptoms (β = 0.03, t = 2.95, P = .002). CLINICAL IMPLICATIONS: It is important for health care providers to ask women about this problem and understand the factors that may influence sexual problems in menopause. STRENGTHS & LIMITATIONS: A validated survey tool was used. The limitation was selection of participants in the clinical setting and sample population size. CONCLUSION: Sexual problems were much more common in women who did not use hormone therapy and showed no somatic symptoms. Dąbrowska-Galas M, Dąbrowska J, Michalski B. Prevalence and Associated Risk Factors of Sexual Problems Among Polish Middle-Aged Women. Sex Med 2019;7:472–479.
format Online
Article
Text
id pubmed-6963159
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69631592020-01-22 Sexual Dysfunction in Menopausal Women Dąbrowska-Galas, Magdalena Dąbrowska, Jolanta Michalski, Bogdan Sex Med Women's Sexual Health INTRODUCTION: Hormone-related changes in menopause may negatively affect sexual function. AIM: The primary aim of this study was to evaluate sexual functioning in Polish women with the Female Sexual Function Index (FSFI). The secondary aim was to evaluate the major factors affecting sexual functions in middle-aged Polish women. METHODS: The Menopause Rating Scale was used to assess the menopausal symptoms. The Polish translation of the FSFI was used to assess sexual function. OUTCOMES: 69.73% of respondents had sexual dysfunction according to FSFI (FSFI score ≤ 26.55). RESULTS: 80.61% of women experienced menopausal symptoms during the 4-week period of study. Psychological and urogenital symptoms were the most frequently reported among all the women enrolled in the study (78.23% and 77.21%). Sexual problems were observed in women who did not use hormone therapy (β = 0.09, t = −1.97, P = .048) and showed no somatic symptoms (β = 0.03, t = 2.95, P = .002). CLINICAL IMPLICATIONS: It is important for health care providers to ask women about this problem and understand the factors that may influence sexual problems in menopause. STRENGTHS & LIMITATIONS: A validated survey tool was used. The limitation was selection of participants in the clinical setting and sample population size. CONCLUSION: Sexual problems were much more common in women who did not use hormone therapy and showed no somatic symptoms. Dąbrowska-Galas M, Dąbrowska J, Michalski B. Prevalence and Associated Risk Factors of Sexual Problems Among Polish Middle-Aged Women. Sex Med 2019;7:472–479. Elsevier 2019-07-29 /pmc/articles/PMC6963159/ /pubmed/31371259 http://dx.doi.org/10.1016/j.esxm.2019.06.010 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Women's Sexual Health
Dąbrowska-Galas, Magdalena
Dąbrowska, Jolanta
Michalski, Bogdan
Sexual Dysfunction in Menopausal Women
title Sexual Dysfunction in Menopausal Women
title_full Sexual Dysfunction in Menopausal Women
title_fullStr Sexual Dysfunction in Menopausal Women
title_full_unstemmed Sexual Dysfunction in Menopausal Women
title_short Sexual Dysfunction in Menopausal Women
title_sort sexual dysfunction in menopausal women
topic Women's Sexual Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963159/
https://www.ncbi.nlm.nih.gov/pubmed/31371259
http://dx.doi.org/10.1016/j.esxm.2019.06.010
work_keys_str_mv AT dabrowskagalasmagdalena sexualdysfunctioninmenopausalwomen
AT dabrowskajolanta sexualdysfunctioninmenopausalwomen
AT michalskibogdan sexualdysfunctioninmenopausalwomen